The trial, which used interferon beta, showed that patients who were given Synairgen#39;s formulation had a 79 percent lower risk of developing severe disease compared to placebo.from Moneycontrol Business News https://ift.tt/2OCsu2y
Monday, July 20, 2020
Synairgen#39;s drug shows reduced risk of severe disease in COVID-19 patients
The trial, which used interferon beta, showed that patients who were given Synairgen#39;s formulation had a 79 percent lower risk of developing severe disease compared to placebo.from Moneycontrol Business News https://ift.tt/2OCsu2y
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment